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ABSTRACT 
A Comparative Study of Seizure Susceptibility and Serum Calcium, 
Magnesium and Phosphorus Profiles of Magnesium Deficient Rats 
by 
Nicole H. Bernhard, Master of Science 
Utah State University, 1982 
Major Professor: Arthur w. Mahoney, Ph.D. 
Department: Nutrition and Food Science 
Magnesium deficiency in rats is known to precipitate audiogenic 
seizures. An unknown mineral factor in a diet mixture was found to 
substantially reduce the seizure occurence in magnesium deficient 
vii 
animals. This was corrected when the same mineral mixture was remade. 
Subsequently the faulty mineral mixture was discarded. This research 
.. as aimed at determining the mineral factor responsible for the observed 
changes in seizure occurence, and also aimed at investigating the 
relationships of serum calcium, magnesium and phosphorus concentrations 
to seizure susceptibility. Treatments to change the serum 
concentrations of these minerals included dietary manipulation, 
subcutaneous injection of calcitonin, of 1 ,25-dihydroxycholecalciferol, 
of calcium and of phosphorus. Animals fed magnesium deficient, low 
phosphorus diet and magnesium deficient animals fasted over-night were 
found to have significantly lower audiogenic seizure susceptibility than 
all other magnesium deficient animals regardless of treatment. Reduced 
viii 
audiogenic seizure susceptibility was not produced by any of the 
injections. The reduction in seizure with the magnesium deficient, low 
phosphorus diet indicates that phosphorus is an important factor in the 




A thorough description of the characteristics of magnesium 
deficiency in rats was given by Kruse et al., in 1932. The observations 
vhich they made and the time table which they established for the 
appearance of certain symptoms have been confirmed by many others 
(Martindale and Heaton, 1968; Smith and Nisbet, 1968; Bucket al., 1976, 
l978a). Among the characteristic symptoms of magnesium deficiency are 
hyperexcitability and seizure susceptibility. Collins (1972) gives a 
thorough description of the characteristics of audiogenic seizures in 
mice, and the audiogenic seizures observed in magnesium deficient rats 
follow this description. It is believed that audiogenic seizures in 
animals may provide a model for studies on epilepsy (Bucket al., 1978a; 
Collins, 1972), though the mechanisms for the seizuring are not known at 
this time. The mechanisms behind the changes in excitability are also 
unknown, though much research has been directed to this problem. 
From previous work (Mahoney, unpublished observations) it has been 
concluded that fasting of magnesium deficient animals overnight prevents 
seizures in these animals when they are subjected to the sounding of a 
school buzzer. It has also been shown that low serum magnesium does not 
necessarily accompany seizure susceptibility, but that low magnesium 
levels in the cerebro-spinal fluid (CSF) does accompany seizure 
susceptibility (Bucket al., 1978b). The purpose of this thesis was to 
study concentrations of serum calcium and phosphorus and determine if 
seizure susceptibility in magnesium deficient rats is affected by 
changes in these minerals. 
Magnesium, Calcium and Phosphorus Interrelationships 
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There is a close metabolic interrelationship between magnesium and 
calcium, and between calcium and phosphorus in animal systems, and the 
serum levels of each influence the homeostasis of the others (Anderson 
and Draper, 1972; Rogers and Bergstrom, 1971; Talmage et al., 1973; 
Grabie et al., 1978; Forbes and Parker, 1980; Shils, 1980). Phosphorus 
depletion has been found to cause significant increases in the excretion 
of magnesium and significant decreases in blood magnesium concentrations 
(Kreusser et al., 1978). Hypercalciuria has also been found to result 
from phosphorus depletion (Cuisinier-Gleizes et al., 1976; Kreusser et 
al., 1978). These changes in magnesium and calcium metabolism may in 
fact be due to phosphorus depletion changing renal filtration of these 
minerals (Lau et al., 1979), which itself may be due to a phosphorus 
effect on Parathyroid Hormone (PTH), which is known to have a marked 
effect on renal filtration. The effects of PTH in animal systems will 
be discussed elsewhere in this section. 
Magnesium deficiency is known to result in hypercalciuria and 
hypercalcemia (Rude and Singer, 1981; Petith and Schedl, 1977). These 
elevated states result in part from changes in the renal treatment of 
calcium, in bone mineral mobilization, and in changes in intestinal 
calcium diffusion (Hsu-Fang et al., 1978). Changes in PTH are suspected 
as the underlying cause of some of these changes (Buckle et al., 1968; 
Reddy et al., 1973; Anast et al., 1976; Shils, 1980). 
Phosphorus and calcium must be present for some of the 
characteristic symptoms of magnesium deficiency to appear (Forbes, 
1963). O'Dell et al. (1960) found that phosphorus and calcium both 
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increase the magnesium requirement in rats. Previous work with 
manipulation of dietary minerals gave rise to changes in seizure 
susceptibility (Mahoney, and Buck, unpublished observations). It was 
suspected that the changes observed were due to modifications in calcium 
and phosphorus content of the diet fed the animals. Clark et al. (1976) 
found that changes in dietary calcium:phosphorus ratios produced large 
changes in thyroidal calcitonin (CT). Calcitonin (CT), like PTH is 
actively involved in the homeostasis of calcium, phosphorus and 
magnesium, as will be discussed later in this section. 
This thesis was directed to determining the factors responsible for 
the changes in seizure susceptibility described above. 
Horomonal Regulation of Blood Calcium, Magnesium and Phosphorus 
Hormonal regulation of the blood levels of calcium, magnesium and 
phosphorus is complex. Many hormones are involved, and researchers have 
documented an especially close interaction between CT, PTH, and 
1 ,25-dihydroxycholecalciferol (1 ,25 DHCC, the active form of Vitamin 
D
3
), in this regulation (Rasmusen and Feinblatt, 1971; DeLuca, 1980; 
Kawashima et al., 1981). This thesis will be dealing with CT and 
1 ,25 DHCC, and with PTH as it relates to the other two. 
CT and PTH are of primary importance in the regulation of calcium. 
CT acts to protect against hypercalcimia, and PTH acts to protect 
against hypocalcemia. The question of which factor, the mineral level 
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or the hormone, triggers changes in the other, and the problems of 
designating the primary site of action by the factor, are still being 
investigated (Lee et al., 1980; Lee et al., 1981; Suki and Rouse, 1981 ). 
In the case of PTH it is believed that low blood calcium stimulates the 
release of the hormone (Guyton, 1981), which in turn acts to elevate the 
calcium blood level. CT is also believed to act in response to calcium 
levels, high blood calcium, and its function is to return these to 
normal levels. 
Injection of rats with either PTH or CT has been shown to change 
the blood calcium levels of these animals (Talmage, 1975), the mechanism 
of which may involve changes in renal filtration and reabsorption 
(Quamme, 1980; Poujeol et al., 1980; Berndt and Knox, 1980). The 
specific renal areas to which the hormonal actions are directed have yet 
to be defined (Suki and Rouse, 1981; Kawashima et al., 1981). 
1 ,25 DHCC is also important in the regulation of blood calcium 
(Kumar and Riggs, 1981). The renal system has been found to play an 
important role in the regulation of 1 ,25 DHCC levels circulating in 
animal systems (Castillo et al., 1981), and PTH and CT have both been 
found to have stimulatory effects in the kidney on 1 ,25 DHCC production 
from its precursors (Kawashima et al., 1981). The mode of action for 
this stimulatory effect is still under investigation, but the 
interaction illustrates that the functions of PTH, CT and 1 ,25 DHCC are 
closely related and give rise to a complex mechanism for mineral 
regulation. 
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Mode of Action: 1 ,25-Dihydroxycholecalciferol. 
1 ,25 DHCC is believed to be involved in enhanced calcium absorption 
in the intestine (Olson and DeLuca, 1969; Hodgkinson et al., 1979) and 
there is evidence that the enhanced absorption is due to a change in the 
amount of a calcium-binding protein (CaBP) present in the intestine 
(Hamilton and Holdsworth, 1975). The suggested relationship of 
1,25 DHCC to the CaBP is that 1 ,25 DHCC binds to the active site of the 
protein thereby affecting the activity of the CaBP (Eisman and DeLuca, 
1977). 
The action of 1 ,25 DHCC has been found to change depending upon the 
age of the animals to which it is administered. Halloran and DeLuca 
(1980) have found that in suckling rats 1,25 DHCC does not affect 
calcium absorption from the intestine, but that it does affect the 
maintenance of blood calcium. As the animals' age increased, the 
influence of the 1 ,25 DHCC to be in both calcium absorption and in blood 
calcium regulation if the Holloran and DeLuca observations are 
characteristic of 1,25 DHCC activity. 
Mode of Action: Parathyroid Hormone. 
The complexity of the interaction between phosphorus, calcium and 
magnesium and PTH renders an understanding of the mechanisms of the 
functions of PTH difficult. The regulation of calcium and phosphorus 
homeostasis is the primary function of PTH. PTH helps maintain their 
proper serum levels through regulation of bone resorption and formation, 
of kidney filtration and of their absorption from the gastro-intestinal 
(GI) tract (Moore, 1971; Goodhardt and Shils, 1980). The mechanism of 
action for PTH varies according to the site at which it is directed. In 
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the kidneys, PTH increases phosphorus excretion and decreases calcium 
excretion (Irving, 1973; Vaughan, 1975). It also affects renal 
filtration of magnesium (Ebel and Gunther, 1980). It is believed that 
the changes in filtration of these minerals is due to the stimulation of 
adenylate cyclase in cells with appropriate receptor sites for PTH. 
This stimulation leads to increased cyclic AMP (cAMP) concentration in 
the target cells (Borle, 1974; Wrenn and Biddulph, 1979) which in turn 
leads to the physiological changes in filtration (Vaughan, 1975; Wrenn 
and Biddulph, 1979). 
In bone tissue, PTH modifies osteoclast and osteoblast metabolism 
such that an increase in bone resorption occurs (Borle, 1974; Holtrop et 
al., 1979). As in the kidneys, the changes which occur are thought to 
be a result of increased cAMP in the cells with receptor sites for PTH 
(Vaughan, 1975). 
Action of PTH in the GI tract is still under investigation, and is 
an area of controversy. It is believed that both PTH and 1 ,25 DHCC must 
be present for absorption of calcium (Irving, 1973; Davidsohn and Henry, 
1974) while PTH may be involved in an increased cAMP concentration in 
target cells of the GI tract. PTH plays a role in the formation of 
1,25 DHCC from the precursor vitamin D (Guyton, 1981; DeLuca, 1979 as 
cited by Castillo et al., 1981), but it is not believed to be involved 
in the formation of the other vitamin D metabolites (Castillo et al., 
1 981 ) • 
PTH has been associated with mechanisms other than those involved 
in calcium, magnesium and phosphorus homeostasis, but these will not be 
discussed here (Bogin et al., 1980). 
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Mode of Action: Calcitonin. 
Injection of CT into mammals has been found to cause a rapid 
decrease in blood calcium and inorganic phosphate (Care and Bates, 
1970). The reduction in calcium is believed to be due to the hormone 
acting on bone osteoclasts (Vaughan, 1975) and other cells and 
preventing the movement of calcium out of them, while not affecting the 
movement in (Borle, 1969). There appears to be an adenylate cyclase 
mechanism in bone and kidney cells, similar to that of PTH, (Marx et 
al., 1972) which may be responsible for the hypocalcemic effect of CT. 
This receptor site mechanism is believed to have receptor sites specific 
to CT, as the adenylate cyclase mechanism of PTH has receptor sites 
specific to it. 
It appears that CT has an effect in both bone and kidney tissue 
which affects calcium concentrations in the blood, though the extent, 
the significance, and the mode of actions are still being investigated. 
Physiological Roles of Calcium, Magnesium and Phosphorus 
Physiological Role of Calcium. 
Calcium plays an important role in many physiological systems. In 
addition to its vital role in proper bone growth and mineralization, 
calcium is essential for blood clotting and for the regulation of ionic 
transport across cell membranes (Pike and Brown, 1975). For muscle 
excitation and neuromuscular transmission, calcium and magnesium act on 
the membrane and alter its permeability to other ions, especially to 
sodium and potassium (Frankenhaueuser and Hodgkin, 1957; Guyton, 1981). 
In this way calcium is actively involved in establishing the action 
8 
potential of nerve cells. The action potential is the mechanism by 
which nerve impulses are transmitted. In addition to its role in 
establishing the action potential, calcium is essential for the release 
of acetylcholine from the neuromuscular junction. Acetylcholine is a 
key agent involved in stimulation of the action potential. Once 
stimulation has occured, there is a release of calcium from the 
sarcoplasmic reticulum of muscle fibers which in turn triggers the 
contraction mechnism of the muscle. This simplified description applies 
to skeletal muscle and to smooth muscle tissues with only a few small 
variations between them. In smooth muscle the process of excitation 
occurs more slowly, and the release of calcium from the sarcoplasmic 
reticulum does not occur. Rather, there is an influx of calcium into 
the muscle cell from the extracellular fluid. 
Physiological Role of Magnesium. 
Magnesium, similarly to calcium, alters the permeability of cell 
membranes to other ions in additon to its vital roles as an enzymatic 
cofactor and as a component of all phosphate transfer systems (Pike and 
Brown, 1975). Through its effects on cell permeability, magnesium can 
influence the fine balance of the neural excitation system, and high 
magnesium does in fact act as an antagonist to calcium in this system 
(Guyton, 1981; Ebel and Gunther, 1980). High magnesium is known to 
block, or greatly reduce, the release of acetylcholine from the 
neuromuscular junction (del Castillo and Engbaek, 1954; Ebel and 
Gunther, 1980). When magnesium is found at high levels it has been 
found to have a sedative effect on the neural system (Mordes and Wacker, 
1978 ) while in deficiency states it has stimulatory properties as 
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evidenced by hyperexcitability (Kruse et al., 1932; Bucket al., 1976). 
Magnesium concentrations have also been found to affect (Na-K)-ATPase, 
an enzyme actively involved in the neural system. Buck et al. (1980) 
discuss this role of magnesium, with possible application to magnesium 
deficiency states. 
Physiological Role of Phosphorus. 
Phosphorus is one of the major anions found in cells and as a major 
component of the energy compound ATP it is essential to all cell 
functions. In this manner it is closely related to calcium and to 
magnesium. High phosphorus intake leads to hypocalcemia (Bell et al., 
1977) while phosphate depletion leads to hypomagnesemia and 
hypercalcemia (Kreusser et al., 1978). A specific description of the 
functions of phosphorus is difficult because of the ubiquitous nature of 
this mineral, yet its close interaction with calcium and magnesium 
supports the contention that phosphorus is involved in many of the same 
functions as these other two minerals. 
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MATERIALS AND METHODS 
General Procedures 
Animal Care 
Male weanling Sprague-Dawley rats, obtained from Simonsen Lab, 
Inc., Gilroy, California, were used throughout. The animal weights on 
day one of the experiments varied from 49-72 g with the majority of the 
animals weighing between 55 and 65 g. Animals were given Purina animal 
chow for at least 12 h prior to the start of the experiment. Animals 
vere housed individually in stainless steel cages with wire mesh fronts 
and floors. Deionized H20 and experimental diet was available ad 
lib, unless the animals were to be fasted, in which case, the food was 
removed 12-18 h prior to testing. Clean H20 was given after 8 days. 
The animal room was light and temperature controlled. Lights were on 
from 0800 to approximately 1900, and the temperature was kept between 22 
and 28 C. Test day procedures consisted of weighing the animals, 
assigning scab scores (scores ranged from 0, no scabs, to 5, severe 
scabs and dermatitis on head and ears), seizure testing them, and then 
collecting blood samples via retro-ocular puncture. Seizure tests were 
performed by placing the rats in a divided stainless steel cage which 
was in turn placed within a sound chamber. They were then subjected to 
the sounding of a school buzzer for 90 seconds, or until seizing 
occured. This follows the method used by Buck et al. (1978a) except 
that the use of the divided stainless steel cage allowed testing of 
animals two at a time instead of singly. 
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Dietary Ingredients 
Diet consisted of 20% casein, 63% dextrose, 5% corn oil, 2% vitamin 
mix, 5% mineral mix, 5% fiber (wood cellulose, obtained from Brown Co, 
Berlin, N.H). The vitamin mix composition (ICN Pharmaceuticals) is 
listed in table 1. The compositions of the mineral mixes are listed in 
tables 2, 3, 4, and 5. 
Analysis of representative diets was made by ashing 1.0-2.0 g of 
diet for 48 h at 550 C. After cooling, 5.0 ml of 6 N HCl was added and 
the samples were slowly heated for 10-20 minutes. They were then diluted 
to 100 ml with distilled H20, and then analysed for calcium, 
magnesium, phosphorus, the results of which are shown in table 6. 
Mineral Analyses 
Calcium and magnesium analyses of all samples were performed using 
an Instrumentation Laboratories 457 Atomic Absorption Spectrophotometer. 
Lanthanum solutions used in these analyses to eliminate phosphate 
interference were made as follows: 
(1) 100,000 ppm LaC1
3
; 66.79 g Lac1
3
-1H20 dissolved in 5 ml 
of HCl and diluted to 250 ml with deionized H
2
o. (2) 100,000 ppm 
La2o3 ; 234.40 g La2o3 dissolved in 440 ml HCl and 
diluting to 2000 ml with deionized H
2
o. 
Phosphorus analyses of all samples were performed using the method 
of Gomori (1942) modified to accomodate microsamples of serum. Samples 
R were read using a Beckman DU -8 spectrophotometer, at 660 nm. 
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Table 1. Vitamin mix composition. 
Vitamin Amount/kg mix Amount/kg diet 
Alpha Tocopherol 5.0 g 11 o.o mg 
1-Ascorbic acid 45.0 g 99.0 mg 
Choline chloride 75.0 g 1. 65 g 
D-Calcium pantothenate 3.0 g 66.0 mg 
i-Inositol 5.0 g 110.0 mg 
Mendadione 2.25 g 49-5 mg 
Niacin 4-5 g 99.0 mg 
p-aminobenzoic acid 5.0 g 110 .o mg 
Pyridoxine-HCl 1.0 g 22.0 mg 
Riboflavin 1.0 g 22.0 mg 
Thiamine-HCl 1.0 g 22.0 mg 
Biotin 20.0 mg 0.44 mg 
Folic acid 90.0 mg 1.98 g 
Vitamin B12 1.35 mg 0.03 mg 
Vitamin A acetate 900,000 . * ]..U. 19,800 . * l.U. 
Calciferol-D
2 100,000 
. * ]..U. 2,200 . * l.U. 
Dextrose to 1000 g to 22 g 
* i.u=international units 
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Table 2. Mineral pre-mix. 
Mineral Amount/kg pre-mix Amount/kg mineral mix 
Znso
4
.7H20 1 • 176 g 5.9 mg 
Mnso
4
.H20 3.420 g 17.3 mg 
Cuso
4
.5H20 0.442 g 2.2 mg 
Na2Mo.2H20 0.012 g 0.1 mg 
KI 0.004 g 0.02 mg 
CoCl
2
.6H20 0.004 g 0.02 mg 
Table 3. Magnesium deficient mineral mix. 
Mineral Amount/kg mineral mix Amount/kg diet 
Caco
3 
280.000 g 14.0 g 
NaH2Po4 341 .ooo g 17.05 g 
KCl 76.300 g 3.82 g 
Feso
4
.7H20 3.500 g 175.0 mg 
Mineral pre-mix 5.058 g 252.9 mg 
Dextrose to 1000 g to 50 g 
For normal diet Mg was supplied by adding 1 .40 g MgC0
3
/kg diet. 
Table 4. Magnesium deficient, low phosphorus mineral mix. 
Mineral Amount/kg mineral mix Amount/kg diet 
Caco
3 
280.000 g 14.0 g 
Naco
3 205.000 g 10.25 g 
KCl 76.300 g 3.82 g 
Znso
4
.7H20 1 .176 g 58.8 mg 
MnS0
4
.H20 3-420 g 171 • 0 mg 
Cuso
4
.5H20 0.442 g 22.1 mg 
NaMo0
4
.2H20 0.012 g 0.6 mg 
KI 0.004 g 0.2 mg 
CoCl2 .6H20 0.004 g 0.2 mg 
Dextrose 566.358 g to 50 g 





Table 5. Magnesium deficient, low calcium and low phosphorus 
mineral mix. 
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Cuso
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CoCl2 .6H20 0.004 g 0.2 mg 
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Due to the nature of the data collected, statistical analyses were 
limited to those data which were the most consistent. Means were 
calculated for all serum analyses, with an edited mean being used in the 
analysis of variance. The edited mean was calculated by eliminating 
data values which appeared to be out of line with the majority of the 
data for a given group. Both the edited and the unedited means are 
reported, the unedited mean being put in parenthesis. Calculation of 
the mean for the mineral ratios was calculated in a similar manner when 
the data were inconsistent. Analysis of variance (ANOVA) was performed 
on experiments I, III, and IV using a randomized block design, and using 
only values included in the computation of edited means. A LSD was 
computed (P<.05) for all significant F ratios (.95). Mean differences 
must equal or exceed the LSD to be significantly different at P<.05. 
Experimental Procedures 
Experiment I: Effects of Low Calcium 
and Low Phosphorus Diets. 
Animals were randomly assigned to one of four dietary groups: 
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(1) magnesium deficient, (2) magnesium deficient fasted over-night, (3) 
magnesium deficient-low calcium and low phosphorus, (4) magnesium 
deficient-low phosphorus. They were fed Purina animal chow for about 5 
days prior to the start of the experiment. This increased the average 
weight on day one to 66 g. Animals were tested on day 17, beginning at 
1400. Testing was done across treatments, two animals at a time. Blood 
was collected approximately 2 h after testing except in a random 
sampling of animals which were bled prior to testing. Brain and tail 
specimens were taken after the blood had been collected. Brain 
specimens were individually wrapped in plastic-wrap and frozen for later 
analysis. Tails were labeled, bagged by group and then frozen for later 
analysis. 
The blood was allowed to clot at room-temperature for approximately 
2 h. It was then centrifuged at 1500 rpm for 30 minutes. Serum was 
removed using Pasteur pipettes and placed in new test tubes. The serum 
was refrigerated for approximately 18 h, after which time it was again 
centrifuged. Known volumes of serum were removed and placed in new test 
tubes and stored until dilutions were made. 
Dilutions for magnesium and calcium analyses were made by adding 
0.1 ml of serum (using SMI Micropettors, Emeryville, Calif) to 1.0 ml of 
100,000 ppm lanthanum solution in an acid washed 10 ml volumetric flask, 
and made to volume with deionized H2o. The final dilution factor was 
equal to 100. 
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Analysis of the brain specimens consisted of weighing each sample, 
placing it in an acid washed porcelain crucible, heating it on a hot 
plate to drive off the moisture, and then ashing it in a muffle furnace 
for 48 h at 550 c. When cooled, 5 ml of a 3:1 Nitric Acid:Water mixture 
was added and the samples were re-ashed over-night at 550 C. After 
cooling, 5 ml of 6 N HCl was added to each sample and they were slowly 
heated. The contents of each crucible was then diluted to 100 ml with 
deionized H2o. For magnesium analysis, 1 ml of this solution was 
added to 10 ml of 10,000 ppm lanthanum solution for a final dilution 
factor of 1100. 
Tail preparation involved boiling the specimens in deionized 
H20 for l h. Tissue was then removed by rubbing the specimen under 
running deionized H2o. Three caudal vertebrae, closest to the tail 
origin, were taken, dried in an oven at 100 C for 1 h, cooled, weighed, 
and then ashed for 48 h at 550 C in an acid washed porcelain crucible. 
After cooling, 5 ml of 6 N HCl was added to each sample and crucibles 
were slowly heated before diluting to 100 ml with deionized H
2
o. Of 
this solution, 1 .0 ml was added to 10 ml of 10,000 ppm lanthanum 
solution for a final dilution factor of 1100. For calcium analysis 
samples were diluted to a final factor of 1015 by adding 0.15 ml of the 
tail dilution to 10 ml of lanthanum solution. 
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Experiment II: Effects of 1,25 DHCC Injection. 
Animals were randomly assigned to one of the following four groups: 
(1) magnesium deficient+ 1,25 DHCC injection, (2) normal+ 1,25 DHCC 
injection, (3) normal + sham injection, (4) magnesium deficient + sham 
injection. All animals were fed animal chow for 3 days prior to the 
start of the experiment. Animals were tested on day 17, 12 h after 
having an intraperitoneal injection of 0.7 ml of either the 1,25 DHCC or 
of the sham solution. Seizure testing was performed across treatments, 
2 animals at a time, beginning at 0800. 
1 ,25 DHCC was a gift from Dr. W.E. Scott of Roffman-La Roche 
Laboratories (Nutley, New Jersey). To solubilize the 1,25 DHCC, 0.5 mg 
was combined with 5 ml of a carrier composed of 40% propylene glycol, 
10% ethanol, and 50% boiled deionized H
2
o. Of this solution, 1.0 ml 
was then diluted to 250 ml with physiological saline. This gave a final 
concentration of 960 pmoles 1 ,25 DHCC per ml of solution. The 0.7 ml 
injection provided 650 pmoles of 1 ,25 DHCC to each animal (Tanaka and 
DeLuca, 1974). The sham solution was physiological saline since, of the 
DHCC solution, only 0.4% was carrier. 
Blood was collected as in Experiment I and allowed to clot for 
approximately 3 h at room temperature. It was then centrifuged at 2000 
rpm for about 30 minutes. The serum was then drawn off using Pasteur 
pipettes, and put into clean test-tubes. If necessary, the serum was 
re-centrifuged to remove any traces of red blood cells. The serum was 
stored refrigerated until dilutions were made. 
Serum dilutions were made in the same manner as in Experiment I 
except that La2o3 was used in place of LaC13-7H20, in 
the lanthanum solution. The final dilution factors remained the same. 
21 
Experiment III: Effects of Calcitonin Injection. 
Animals were randomly assigned to one of five dietary and treatment 
groups: (1) magnesium deficient+ Calcitonin injection, (2) normal+ 
Calcitonin injection, (3) magnesium deficient control, (4) normal 
control, (5) magnesium deficient-low phosphorus. They were fed animal 
chow for 12 h prior to the start of the experiment. The animals were 
tested on day 17 beginning at 0800. Seizure testing was performed 1 h 
after animals had been injected intraperitoneally with CalcimarR 
(Armour Pharmaceuticals, Chicago, Illinois). The CalcimarR 
(Calcitonin) solution was prepared by diluting ml of CT (200 MRC/ml) 
to 50 ml with physiological saline. This gave a final concentration of 
4 MRC/ml. The injection dose was then adjusted to provide 2 MRC/100 g 
of body weight, as suggested by Nakhla (1979). 
Blood was collected as in previous experiments. After clotting at 
room temperature for about 2 h the blood was centrifuged at 2000 rpm for 
45 minutes. Serum was removed and diluted that day. For magnesium and 
calcium analyses, dilutions were made by pipetting 10 ml of 10,000 ppm 
lanthanum solution into test tubes, and adding 0.1 ml of serum. This 
gave a final dilution factor of 101. 
Experiment IV: Effects of Calcium 
or Phosphorus Injection. 
Animals were randomly assigned to one of six dietary or treatment 
groups: (1) magnesium deficient+ 20 mM calcium injection, (2) 
magnesium deficient + 5 mM calcium injection, (3) magnesium deficient 
control, (4) magnesium deficient control, (5) magnesium deficient + 10 
mM phosphorus injection, (6) magnesium deficient + 2.5 mM phosphorus 
injection. They were fed animal chow for 12 h prior to the start of the 
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experiment. Groups 1, 2, and 3 were seizure tested on day 16, beginning 
2 h after intraperitoneal injection of the calcium treatment solutions. 
Groups 4, 5, and 6 were seizure tested on day 17, beginning 2 h after 
intraperitoneal injection of phosphorus treatment solutions. 
Group 1 was injected with 1 .5 ml of 20 mM calcium solution made by 
dissolving 1.25 g of Caco
3 
in 2.0 ml glacial acetic acid, and 
bringing up to 500 ml volume with deionized water. This solution 
provided enough calcium to raise the blood concentration to twice its 
normal value (.003M), if it were totally absorbed. Group 2 was injected 
with 1.5 ml of 5 mM calcium solution. This was made by diluting 25 ml 
of the 20 mM solution to 100 ml with deionized water. The solution 
provided enough calcium to raise the blood level concentration by 1/2 
its normal level if it were totally absorbed. 
Group 5 was injected with 1.5 ml of 10 mM phosphorus solution made 




and pellet of NaOH (to help 
adjust pH to 7.0) to 500 ml with deionized H
2
o. This supplied 
enough phosphorus to raise the blood concentration to 2 times its normal 
level (3.13 mM), if the phosphorus were totally absorbed. Group 6 was 
injected with 1.5 ml of 2.5 mM phosphorus solution made by diluting 25 
ml of the 10 mM solution to 100 ml with deionized water. 
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RESULTS AND DISCUSSION 
Symptomatology 
Magnesium deficiency symptoms, vasodilation of the ears and 
extremities and hyperexcitability, occured as expected according to the 
time-table established by Kruse et al. (1932). Animals fed normal basal 
diet (magnesium supplemented) developed no deficiency symptoms, as 
projected. The degree of hyperexcitability observed in the deficient 
animals varied from experiment to experiment, and not among groups 
within experiments. Animals in Experiment II behaved such that each day 
approximately 3/4 of their food was wasted due to digging and/or 
overturning of the feed cups. Anchoring of the cups and use of 
anti-digging rings helped only minimally. The animals continued to 
overturn the feed cups in spite of the preventive measures. This 
behaviour was unique to these animals. A few animals in other 
experiments also wasted food, but in these cases anchoring of the feed 
cups and use of the anti-digging rings alleviated the problem. Animals 
in Experiment III demonstrated unusually aggressive behaviour. They 
were highly irritable and very apt to jump at, and be successful in 
biting those handling them. This type of nastiness was also seen in a 
few of the animals in Experiment IV, but it was by no means as 
characteristic of, or as severe in Experiment IV. The animals of 
Experiment I demonstrated classic hyperexcitability, but displayed no 
unique behavioural characteristics. The differences in behaviour 
between experiments was probably due to the animal variation between 
sets, rather than to experimental conditions and treatments since all 
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animals were housed, fed and cared for in a similar manner, and that 
animals were subjected to the various treatments in the last 24 hours of 
the experiments, except in Experiment I, where dietary treatments were 
begun on day 1. 
Scab scores assigned on test day ranged from 0 (no scabs) to 5 
(severe scabs and dermatitis on head and ears) in magnesium deficient 
animals. Those fed the magnesium deficient, low calcium, and low 
phosphorus diet (Experiment I, group 3) had the most severe cases of 
scabbing, and the greatest number with high scores, but also had a high 
number of animals with no scabs (9/14). Scabbing therefore seemed to be 
more a function of individual animal behaviour than of diet, within 
magnesium deficient groups. Scab scores were not found to correlate 
with seizure susceptibility. Rather, some of the animals with the most 
severe scabs did not seize, while animals which appeared quite normal 
inspite of the magnesium deficient diet did seize. An example of the 
latter, was seen in animals fed a magnesium deficient, low calcium diet 
(preliminary experiment, see appendix E). These animals had a greatly 
reduced incidence of the physical symptoms of magnesium deficiency, 
nhile having a high susceptibility to seizures (100%). This confirms 
the results of Forbes (1963) that low dietary calcium prevents the 
physical appearance of magnesium deficiency. 
Seizure Susceptibility and Serum Analyses 
A summary of seizure susceptibility in all experiments can be found 
in table 7. A preliminary experiment on the effects of handling on 
seizure susceptibility and serum mineral concentrations revealed no 
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Table 7. Summary of seizure susceptibility, Experiments I-IV. 
Diet No. seizure/ Percent 
Experiment Group No. animals Seizure No. deaths 
I: Effects; 1:Mg- 8/15 53 0 
Low Ca, 2:Mg-, 2/14 14 0 
Low P diet. fasted 
3:Mg-, 12/14 86 4/14 
P-,Ca-
4:Mg-, 4/15 27 0 
P-
II: Effects; 1 :Mg-, 9/15 60 0 
DHCC inj. 1 ,25 DHCC 
2:normal, 0/15 0 0 
1 , 25 DHCC 
3:normal, 0/10 0 0 
sham 
4:Mg-, 6/10 60% 3/10 
sham 
III:Effects; 1 :Mg-, 11 /15 73 1/15 
CT inj. CT 
2:normal, 0/10 0 0 
CT 
3:Mg-, 5/10 50 0 
cntl 
4:normala 
5:Mg-, 0/10 0 0 
P-
IV: Effects; 1 ::r-ig-, 0/10 70 0 
Ca inj, 20mM Ca 
P inj. 2:Mg-, 7/10 70 2/10 
5mM Ca 
3:Mg-, 8/10 80 2/10 
cntl 
4:Mg-, 7/10 70 0 
cntl 
5:Mg-, 6/10 60 0 
10mM p 
6:Mg-, 7/10 70 0 
2. 5m~1 P 
a 
Group 4 was not seizure tested. 
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changes in these parameters. Animals were bled both before and after 
seizure testing, with no differences in seizure occurence or serum 
mineral concentrations between the animals bled prior to testing and 
those bled after testing. 
Animals which were not fasted, and which were magnesium deficient 
(with or without treatment) had seizure susceptibility of between 50% 
and 70%. The anticipated susceptibility rate was 80% to 90% (Buck et 
al., 1978a, 1978b). The lower rate may be due, in part, to the diet 
containing 5% fat (as corn oil). Mahoney (unpublished observations) and 
Buck et al. (1978a, 1978b) have seen a susceptibility rate of between 80 
and 100% in male weanling rats fed a magnesium deficient diet containing 
10% fat. Further studies need to be conducted using 10% fat in the diet 
in order to investigate a possible relationship between dietary fat 
content and seizure susceptibility. If 10% dietary fat is found to 
increase seizure susceptibility in a constant way, using this level of 
fat in magnes i um deficient diet may facilitate interpretation of changes 
in seizure occurrence. 
Experiment I: Effects of low calcium 
and low phosphorus diet, and 
Experiment III: Effects of Calcitonin injection. 
Seizure susceptibility of the magnesium deficient animals did not 
seem to change with treatments (table 7). A higher susceptibility rate 
(73% ) in magnesium deficient animals injected with Calcitonin (CT) 
(Experiment III, group 1) versus that of the magnesium deficient control 
(50%) (Experiment III, group 3) may not be a reflection of a treatment 
effect, but may simply be due to a low susceptibility of the magnesium 
def i cient control. The low susceptibility of the magnesium deficient 
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controls may be due to the fat content of the diet, or to animal 
variation since other magnesium deficient animals with different 
treatments had similar susceptibilty rates (Experiment I, group 1; 
Experiment II, group 4; Experiment IV, groups 3 and 4). In order to 
determine if treatments reduce susceptibility to seizures in magnesium 
deficient animals, a consistently high susceptibility rate must be 
present in control groups. Conversely, to determine if treatments 
increase seizure susceptibility in magnesium deficient animals, a 
consistently lower susceptibility rate must be present in magnesium 
deficient controls. Further research investigating the relationship of 
seizure susceptibility to dietary fat content may reveal that fat 
content below 5% gives rise to less seizure occurrence in magnesium 
deficient rats. This would permit investigation of factors which might 
increase susceptibility to seizures in magnesium deficient animals. 
The animals fed magnesium deficient, low calcium and low phosphorus 
diet (Experiment I, group 3) seem to have had a higher susceptibility 
(86%), but again, the low rate in the control group not having been 
completely accounted for makes it difficult to definitely attribute the 
higher rate in group 3 to the treatment. The severity of the seizures 
in that group, however, tended to be greater than in the control group, 
and may be indicative of a treatment effect. 
Animals fed a magnesium deficient diet and fasted overnight 
(Experiment I, group 2) had considerably lower susceptibility to seizure 
(14%) than other groups in all experiments with the exception of the 
animals fed magnesium deficient, low phosphorus diet (Experiment I, 
group 4 [27%]; Experiment III, group 5 [o%]) (see table 7). The fasting 
effect has been seen previously (Mahoney, unpublished observations), 
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though the mechanism for the reduction in seizure susceptibility has not 
been determined. The serum analysis of this group revealed 
significantly higher magnesium concentration than the other groups of 
that experiment, while the calcium and phosphorus values fell between 
those of the other groups (table 8). Analysis of the cerebro-spinal 
fluid (CSF) in future experiments may help to determine more precisely 
the mechanisms of the observations made. Buck et al. (1978b) found that 
CSF magnesium concentrations can be indicative of seizure 
susceptibility. The low seizure susceptibility in animals fed magnesium 
deficient, low phosphorus diet was unexpected (Experiment I, group 4; 
Experiment III, group 5; table 7). Previous work, however, indicates a 
need for calcium and phosphorus for the physical symptoms of magnesium 
deficiency symptoms to appear (Forbes, 1963), and an increased dietary 
calcium and phosphorus has also been reported to increase the need for 
magnesium in animals (O'Dell et al., 1960). A preliminary test of 
animals fed a magnesium deficient, low calcium diet revealed no 
reduction or increase in seizure susceptibility compared with magnesium 
deficient controls (Appendix E). From the results of this research and 
those of the preliminary test with animals fed magnesium deficient, low 
calcium diet there is an indication that phosphorus is a determining 
factor for seizures to occur in magnesium deficient animals at the level 
expected (50% or more, in this research). The importance of phosphorus 
may lie in its affecting the Ca:P ratio in the diet, and consequently in 
the animals' systems. Clark et al. (1976) found that changes in Ca:P 
increased thyroidal Calcitonin (tCT). This increase may lead to a many 
changes in calcium, phosphorus and magnesium homeostasis (Poujeol et 
al., 1980; Quamme, 1980), as well as to changes in 1,25 DHCC (Kawashima 
Table 8. Serum Ca, Mg, and P values, Experiment I: Effects of low 






























































abcValues with the same letter designation are not significantly 
different at P<.05. 
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et al., 1981). Low phosphorus diet has also been found to change renal 
filtration of calcium and magnesium (Cuisinier-Gleizes et al., 1976). 
These changes in renal filtration may be a result of phosphorus 
affecting the regulatory hormones such as CT, PTH and 1 ,25 DHCC. 
Animals in which both calcium and phosphorus were not added to the 
diet (Experiment I, group 3) did not show a reduction of seizure 
susceptibility and may in fact have shown an increase, as mentioned 
earlier. A reduction in seizuring when only the phosphorus salt was 
eliminated from the magnesium deficient diet is good evidence for the 
contention that phosphorus is a mineral influencial in the occurrence of 
seizuring of magnesium deficient animals. The absence of a reduction in 
seizure occurrence in animals fed diet deficient in both calcium and 
phosphorus may be due to the Ca:P ratio having not been sufficiently 
disturbed to cause physiological effects. Deficiency of one salt makes 
for a much more obvious disturbance in the Ca:P ratios than the 
elimination of both. Serum phosphorus concentrations in the animals fed 
magnesium deficient, low phosphorus diet (Experiment I, group 4) were 
significantly lower, and those of calcium significantly higher than the 
serum phosphorus and calcium concentrations of the other groups of 
Experiment I (table 8). Serum magnesium remained unchanged compared 
with the magnesium deficient control. The serum concentration of 
calcium and magnesium of the animals fed magnesium deficient, low 
phosphorus diet in Experiment III (group 5) (table 13) were very similar 
to those of group 4, Experiment I (table 8), and served to confirm the 
observations made in Experiment I. There was excess variability, which 
was unexplained, in the serum phosphorus concentration but with the 
simila rity between the other minerals, and the seizure susceptibility of 
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the two groups, it seems reasonable to conclude that these two groups 
serve to confirm the importance of phosphorus in the seizuring process. 
Further research directed to this area may help to determine the 
mechanisms behind the susceptibility changes observed, and may also help 
to learn more about the interaction of calcium, phosphorus and 
magnesium. The roles of CT and PTH with regard to seizure 
susceptibility may also become more clear if one keeps in mind the 
findings of Clark et al. (1976) that changes in Ca:P ratio increased 
thyroidal CT, and the findings of Cuisinier-Gleizes et al. (1976) that 
low phosphorus diets change renal filtration of calcium a~d magnesium, 
the renal system being an important site of hormonal activity. 
Ratios of Ca/Mg and of (Ca+Mg)/P for the animals magnesium 
deficient and fasted over-night (Experiment I, group 2) were 
significantly lower than most of the other groups in the same 
e~periment, and the Ca/Mg and (Ca+Mg)/P ratios for the animals fed 
magnesium deficient, low phosphorus diet were significantly higher than 
most of the other animals in Experiment I (table 9). These 
observations, combined with the serum value comparisions indicate that 
the calcium, magnesium and phosphorus serum contents, or mineral ratios 
do not give an indication of seizure susceptibility as had been hoped 
they would, since group 2 (fasted over-night) and group 4 (low 
phosphorus diet) have opposed serum ratios, different serum 
concentrations, yet similar seizure susceptibility. 
A summary of the results of Experiment III can be found in tables 
12 and 13. The animals to which CT was administered, both magnesium 
deficient (group 1), and normal (group 2) had significantly lower 
calcium values than their respective controls (group 3 and group 4). 
Table 9. Serum Ca/Mg and (Ca+Mg)/P, Experiment I: Effect of low 








































aValues with the same letter designation are not significantly 
different at P<.05. 
1
Values in parenthesis represent unedited means ± s.d. 
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The serum calcium values were somewhat lower than those previously 
reported for animals injected with CT (Talmage et al., 1973), but 
differences in experimental design, such as use of magnesium deficient 
animals versus non deficient animals, may account for these results. In 
their work, Talmage et al. (1973) infused calcium with CT, while in this 
research, CT was injected i.p. with no other factor. The calcium 
infusion with the CT may have contributed to the higher values reported 
by Talmage et al. (1973). The Ca/Mg ratios for groups 1 and 2 were also 
significantly lower than those of their respective controls (group 3 and 
group 4), but the (Ca+Mg)/P ratios were not significantly different. As 
mentioned earlier, it is difficult to see a treatment effect on the 
seizure susceptibility of the magnesium deficient animals. 
Experiment II: Effects of 
1 ,25 Dihydroxycolecalciferol injection, and 
Experiment IV: Effects of calcium 
injection and of phosphorus injection. 
A summary of the respective results of Experiment II and of 
Experiment IV are listed in tables 10-11 and 14-15. Because of such 
excess variability in these results in comparison with values normally 
obtained in serum analyses for calcium, magnesium and phosphorus 
concentrations (Tanaka and DeLuca, 1974; Bucket al., 1976; Castillo et 
al., 1981), a discussion of these experiments is impractical (see 
appendices B and D for data). Close scrutiny of experimental procedures 
revealed no explanation for this excess variability. A run of blanks, 
subject to exact procedures of blood handling and analysis, revealed no 
contamination and failed to reveal any hints for possible explanation of 
the results. Animal behaviour on test day and during testing in these 
experiments was not unusual, as would have been expected if the results 
Table 10. Serum Ca, Mg, and P values, Experiment II1 : Effects of 






























































excess variability which could not be explained. See data, Appendix B. 
2
Two means were calculated for serum Ca because of the large 
difference between 6 samples and the remaining 9. 
3values in parentheses represent unedited means± s.d. 
Table 11. Serum Ca/Mg and (Ca+Mg)/P, Experiment II 1 : Effects of 
1 '25 DHCC injection. 
Group Ca/Mg (Ca+Mg)/P Percent 
Seizure 
1 : Mg-, 14.4±2.0 4.02±0.82 60 
DHCC inj. n=9 n=9 2 7.7±1.94 1 • 61 ::!:0. 1 5 
n=5 n=6 
(13.01±5.33) 3 ( 3. 06± 1 • 38) 
n=15 n=15 
2:Normal, 4.9:!;0.34 2.74:!;0.75 0 
DHCC inj. n=10 n=12 
(6.02;2.26) 
n=12 
3:Normal, 11 • o::o. 95 7.04::1.30 0 
sham inj. n=10 n=10 
4:Mg-, 20.2±2.63 (4.35::!:1.54) 60 
sham inj. n=6 n=7 
( 17. 3±5. 61) 
n=7 
1 
ANOVA was not performed on Experiment II, see footnote 1, table 10. 
2
Two ratios were calculated due to the large difference between six 
of the values and the remaining nine. 
3values in parenthesis represent unedited means± s.d. 
35 
Table 12. Serum Ca, Mg, and P values, Experiment III: Effects of 
CT injection. 
Group 












































1 .96±0.86 a 
n=12 











1Values in parentheses represent unedited means ± s.d. 







3No mean phosphorus value was calculated for group 5 due to the 
excess variability of the data (see Appendix C). 
abValues with the same letter designation are not significantly 
different at P<.05. 
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Table 13. Serum Ca/Mg and (Ca+Mg)/P, Experiment III: Effects of 
CT injection. 
Group Ca/Mg 
1 :Mg-, CT inj. 8.1±2.01 
n=13 
2:Normal, CT inj. 2.6.:!:0.23 
n=10 




4:Normal, control 1 3-8.:0.54 
n=15 




LSD (. 05) 1.14 























2 (Ca+Mg)/P ratio for group 5 was not computed. See appendix C for 
data. 
abcde . Values w1th the same letter designation are not significantly 
different at P<.05. 
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Table 14. Serum Ca, Mg, and P values, Experiment IV: Effects of 
calcium injection and of phosphorus injection. 
Group 
1 :Mg-, 
20 mM Ca 
2: I1g-, 






10 mM p 
6:Mg-, 
2.5 mM P 









20. 7.=1 .46 
n=8 

















































1Values in parentheses represent unedited means .:!:: s.d. 










Values Wlth the same letter designation are not significantly 
different at P<.05. 
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Table 15. Serum Ca/Mg and (Ca+Mg)/P, Experiment IV1 :Effects of 
calcium injection and of phosphorus injection. 
Group 
1 : Mg-, 
20 mM Ca inj. 
2:Mg-, 






10 mM p inj. 
6:Mg-, 
2.5 mM P inj. 
Ca/Mg 


































Analysis of variance was not performed. See data in appendix D. 
Values in this table represent unedited means. 
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obtained were true of the animals' mineral status. The concentration of 
serum magnesium, alone, would indicate that the animals were not 
magnesium deficient yet they displayed the physical and behavioural 
characteristics of a deficiency. The injections of 1 ,25 DHCC in 
Experiment II were expected to raise the serum calcium concentration to 
approximately 12.0 mg/dl, and the phosphorus concentration to 5-6 mg/dl. -
Tanaka and DeLuca (1974) found that intraperitoneal (i.p.) injections of 
1,25 DHCC to rats fed a Vitamin D deficient diet for two weeks gave 
serum values in this range. Castillo et al. (1981) in contrast found 
that 1 ,25 DHCC injections had no effect on serum calcium, but did raise 
serum phosphorus. However, Miravet et al. (1980) found only small 
increases in serum calcium of magnesium deficient rats injected i.p. 
with 325 pmol of 1,25 DHCC and concluded that magnesium deficient rats 
lose their ability to increase serum calcium in response to 1,25 DHCC. 
This could account for the failure of 1 ,25 DHCC injection to affect 
seizure susceptibility. The calcium values resulting from this 
research, in any case are unrealistically high, though the reasons for 
this are unexplained. The injections of calcium solution and of 
phosphorus solution in Experiment IV were to have raised the serum 
calcium and phosphorus concentrations but as in Experiment II the 
results are unrealistically high for not having affected the animals' 
well-being and behaviour. As in Experiment II these results are 
unexplainable. 
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Seizure Susceptibility: Vertabrae and Brain Analyses 
Results from the analysis of the caudal vertebrae of the animals in 
Experiment I (effects of low calcium and low phosphorus diet) are 
summarized in tables 16 and 17, while those of the analysis of the brain 
tissue from these animals are summarized in table 18. There does not 
appear to be any relationship between the calcium and magnesium content 
of the caudal vertebrae and seizure susceptibility, while a comparison 
of the phosphorus content of both groups with low seizure susceptibility 
(group 2, fasted over-night; group 4, low phosphorus diet) showed no 
significant difference between these groups. The values were, however, 
considerably higher than those of the other groups (group 1, magnesium 
deficient; group 3, low calcium and low phosphorus). The Ca/Mg and 
(Ca+Mg)/P ratios do not show any relationship to seizure susceptibility. 
Brain analysis did not reveal any correlation between seizure 
occurrence and magnesium or phosphorus content of the tissue. The 
fasted animals (group 2) had significantly higher brain magnesium 
concentrations than the others, but because the animals fed magnesium 
deficient, low phosphorus diet did not have higher brain values, it is 
difficult to conclude that the higher value observed in group 2 was 
related to the decreased susceptibility. 
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Table 16. Caudal vertebrae Ca, Mg and P values, Experiment I: Effects 
















19.1 :!:0. 90 
n=13 






































aValues with the same letter designation are not significantly 
different at P<.05. 
Table 17. Caudal vertebrae Ca/Mg and (Ca+Mg)/P, Experiment I: 
Effects of low calcium and low phosphorus diet. 
Group Ca/Mg (Ca+Mg)/P 
1 :Mg- 19.0:t2.3 a 1 • 75.±0. 30 
n=15 n=15 
2:Mg-, 18.3±1-7 a 1 • 55:t0.17 
fasted o.n. n=13 n=13 
3:Mg-, 14.5_:2.0 b 1 .22±.0.15 
low Ca, low P n=15 n=15 
4:Mg-, 15-3_:1.9 b 1 • 09.± 1 • 1 2 
low P n=13 n=13 







abValues with the same letter designation are not significantly 
different at P<.05. 
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Table 18. Brain Ca, Mg and P values, Experiment r 1 : Effects of 






low Ca, low 
4:Mg-,low P 


































Calcium values were not obtained as the initial dilution put the 
calcium concentration below 0.5 ppm, concentrations too low to read by 
atomic absorption spectrophotometry. This concentrtion indicated that 
brain tissue calcium concentration were near or below .050 mg/gm 
tissue. 
2
Values in parentheses represent unedited means ± s.d. 
abcValu~s with the same letter designation are not significantly 
different at P<.05. 
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CONCLUSIONS AND RECOHI1ENDATIONS 
From this reseach, it is apparent that phosphorus plays an 
important role in the occurence of seizures in magnesium deficient 
animals. A probe of the mechanisms behind this role would be most 
interesting. It seems likely that changes in the functions of 
calcitonin and parathyroid hormone are affected by the elimination of 
the phosphorus salt from magnesium deficient diet. In future research 
it may be beneficial to analyze for these hormones and changes in their 
levels circulating in the systems. It may also prove beneficial to 
analyze cerebro-spinal fluid (CSF) for its mineral profile. Buck et al. 
(1978a) found that changes in CSF magnesium concentration paralleled 
seizure susceptibility in magnesium deficient rats, while serum 
concentrations did not (Bucket al., 1976). A similar relationship may 
exist with phosphorus. 
The confirmation of previous results (Mahoney, unpublished 
observations) with magnesium deficient rats fasted over-night have 
decreased seizure susceptibility has added another area to be 
investigated with respect to the mechanisms causing seizing. The serum 
analysis of these animals gave no insight as to the reasons for a 
reduction in susceptibility. Analysis of the circulating levels of CT 
and PTH may reveal something, or analysis of the CSF may be helpful in 
the determination of a mechanism causing the seizure occurence. 
Analysis of kidney tissue, in addition to that of brain tissue, may 
provide some information as to changes in the treatment of calcium, 
magnesium and phosphorus by the renal system. With the kidneys a 
primary site of action for CT and PTH some insight might be gained as to 
\1hether these hormones are being affected by the dietary, or other 
treatments, by analyzing this organ. 
46 
This research has demonstrated a lack of correlation between 
seizure susceptibility and serum calcium, magnesium and phosphorus 
concentration, and a lack of correlation between seizure susceptibility 
and Ca/Mg and (Ca+Mg)/P ratios. Determination of similar ratios of CSF 
mineral content may prove to be more helpful. 
In this research it became apparent that the fat content of the 
diet affected seizure susceptibility in the magnesium deficient animals. 
Increasing the seizure susceptibility of these controls to between 80 
and 100%, interpretation of treatment effects would be greatly 
fascilitated. It may be beneficial to carry out some dietary fat 
studies in which the levels of fat range from 5% to 20% to investigate a 
possible relationship between fat content and seizure susceptibility. 
From this research it may be possible to establish a schedule relating 
dietary fat content to seizure susceptibility. Such a schedule would 
allow researchers to determine not only if treatments reduce seizure 
susceptibility, but also to determine if treatments increase 
susceptibility. 
Close control of food intake in future studies related to magnesium 
deficient animals may reveal interesting data as to food consumption 
patterns. The low seizure susceptibility observed in the magnesium 
deficient animals may have been due, in part, to the animals being in a 
refractory state, following spontaneous seizuring, and a reduction in 
food consumption may be occuring during this refractory period. 
Investigation into a possible refractory period may prove to be helpful 
a s well, in the determination of causes of low seizure occurence. 
47 
To prevent excess variability in serum mineral concentrations, it 
may be beneficial to dilute the serum samples for analysis the same day 
that the samples are collected. Handling of the serum in this way may 
prevent the formation of fibrous clots in the serum, which, in this 
research may have contributed to the observed variability in mineral 
values . This would also allow all samples to be prepared within similar _ 
time periods with respect to sample collection. 
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(Ca+Mg)/P 
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Appendix E 
Preliminary Test of Magnesium Deficient, Low Calcium Diet 









Percent animals w/ 
Scab Score=O 
53% 
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